CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 68 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,053 | -98.5% | 18,580 | -97.8% | 0.00% | -100.0% |
Q3 2022 | $136,000 | -40.9% | 827,240 | -9.1% | 0.00% | -40.0% |
Q2 2022 | $230,000 | -52.7% | 910,006 | -0.5% | 0.01% | -44.4% |
Q1 2022 | $486,000 | -16.6% | 914,887 | -3.4% | 0.01% | -10.0% |
Q4 2021 | $583,000 | -40.8% | 947,083 | -2.0% | 0.01% | -44.4% |
Q3 2021 | $985,000 | -46.1% | 966,014 | -3.2% | 0.02% | -45.5% |
Q2 2021 | $1,827,000 | -5.7% | 998,229 | +1.5% | 0.03% | -10.8% |
Q1 2021 | $1,937,000 | +64.4% | 983,279 | +4.4% | 0.04% | +54.2% |
Q4 2020 | $1,178,000 | -43.7% | 942,079 | -19.0% | 0.02% | -52.0% |
Q3 2020 | $2,094,000 | -79.3% | 1,163,430 | -3.4% | 0.05% | -79.9% |
Q2 2020 | $10,105,000 | +57.6% | 1,204,407 | -1.6% | 0.25% | +27.7% |
Q1 2020 | $6,413,000 | – | 1,223,777 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
Platform Technology Partners | 45,000 | $28,000 | 0.01% |
XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |